News | January 28, 2022
Lupin signs promotional agreement with Exeltis on SOLOSEC
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
The companies will continue with their exclusive agreements, including commercialization of their current portfolio
The award was given as a result of NASSCOM's meticulous screening process, in which over 700 start-ups were shortlisted as the most promising companies of the year
Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals
It meets stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for Covid-19
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
New role strengthens Quantori’s global leadership position in data science & digital IT
The covid health center will be managed and administered by the district administration of Ballari
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
The tablet donations provided for the treatment of more than 600 million schoolchildren in affected countries in sub-Saharan Africa since 2007
Subscribe To Our Newsletter & Stay Updated
